News & Updates
Filter by Specialty:
Deep submucosal invasion not independently linked to metastasis in colorectal cancer
04 Jul 2022
In the absence of other histological risk factors, deep submucosal invasion is not strongly predictive of lymph node metastasis in patients with T1 colorectal cancer, reports a recent meta-analysis.
Deep submucosal invasion not independently linked to metastasis in colorectal cancer
04 Jul 2022
Infliximab, adalimumab biosimilars effective, safe in paediatric IBD
27 Jun 2022
byTristan Manalac
The use of biosimilars of infliximab (IFX) and adalimumab (ADA) is both safe and effective in children with inflammatory bowel disease (IBD), inducing high rates of failure-free survival with a low incidence of adverse events, according to a study presented at the 2022 Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN 2022).
